Cite
Dose ranging, expanded acute toxicity and safety pharmacology studies for intravenously administered functionalized graphene nanoparticle formulations
MLA
Richard Z. Lin, et al. “Dose Ranging, Expanded Acute Toxicity and Safety Pharmacology Studies for Intravenously Administered Functionalized Graphene Nanoparticle Formulations.” Biomaterials, vol. 35, no. 25, Feb. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e98f7b2e5d568d6c00d80c6f79864383&authtype=sso&custid=ns315887.
APA
Richard Z. Lin, Balaji Sitharaman, Ya-Ping Jiang, Jimmy Toussaint, Shruti Kanakia, Tanuf Tembulkar, Sayan Mullick Chowdhury, William Moore, Stephen Lee, & Kenneth R. Shroyer. (2014). Dose ranging, expanded acute toxicity and safety pharmacology studies for intravenously administered functionalized graphene nanoparticle formulations. Biomaterials, 35(25).
Chicago
Richard Z. Lin, Balaji Sitharaman, Ya-Ping Jiang, Jimmy Toussaint, Shruti Kanakia, Tanuf Tembulkar, Sayan Mullick Chowdhury, William Moore, Stephen Lee, and Kenneth R. Shroyer. 2014. “Dose Ranging, Expanded Acute Toxicity and Safety Pharmacology Studies for Intravenously Administered Functionalized Graphene Nanoparticle Formulations.” Biomaterials 35 (25). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e98f7b2e5d568d6c00d80c6f79864383&authtype=sso&custid=ns315887.